
On Thursday, October 8, 2026, the College of Pharmacy at Gulf Medical University hosted an Online Research Seminar Series featuring Dr. Lobna Elkhadragy, Research Assistant Professor at the University of Illinois Chicago (UIC), USA. Titled “Precision Modeling of Liver Cancer by Hepatocyte CRISPR Editing,” the seminar focused on the use of CRISPR/Cas9 gene editing in hepatocytes to develop precision preclinical models of liver cancer. Dr. Elkhadragy’s research integrates CRISPR/Cas9 gene editing, primary hepatocyte models, and translational animal models to investigate clinically relevant cancer driver alterations and therapeutic response, with a current focus on the molecular mechanisms underlying liver cancer initiation and therapeutic response. The seminar highlighted the connection between molecular cancer biology, gene editing technologies, and translational research in advancing precision models and therapeutic strategies for liver cancer.
Aligned with the United Nations Sustainable Development Goals (SDGs):
SDG 3: Good Health and Well-being; SDG 4: Quality Education
![]()
![]()


